Cue Biopharma, Inc. CUE
4.15 USD -0.35 (-7.78%)
Regular-session close
4.20 +0.05 +1.20%
After hours · Nov 20, 7:39 PM ET
4.05 Day range 4.90
2.83 52-week range 37.84
- YTD
- -54.64%
- 1 year
- -74.43%
CUE revenue history
Revenue is income from the company’s ordinary business activities.
27,466,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 27,466,000 | 18,179,000 | 195.75% |
| FY 2024 | 2024-12-31 | 9,287,000 | 3,797,000 | 69.16% |
| FY 2023 | 2023-12-31 | 5,490,000 | 4,245,000 | 340.96% |
| FY 2022 | 2022-12-31 | 1,245,000 | -13,696,370 | -91.67% |
| FY 2021 | 2021-12-31 | 14,941,370 | 11,787,045 | 373.68% |
| FY 2020 | 2020-12-31 | 3,154,325 | -304,006 | -8.79% |
| FY 2019 | 2019-12-31 | 3,458,331 | 2,315,727 | 202.67% |
| FY 2018 | 2018-12-31 | 1,142,604 | 1,142,604 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
